FIELD: medicine.
SUBSTANCE: there are produced silk polypeptides having a double-spiral structure and originated from honey bee, bumble bee, bulldog ant, green tree ant and golden-eyed fly. A recombinant method is used to produce a host cell, transgenic plant and animal which produce silk polypeptide. Antibodies are produced for prepared polypeptides.
EFFECT: invention enables using producing silk polypeptides in various fields of industry.
21 cl, 14 dwg, 14 tbl, 10 ex
Title | Year | Author | Number |
---|---|---|---|
ROTAVIRAL PARTICLES WITH CHIMERIC SURFACE PROTEINS | 2014 |
|
RU2698049C2 |
NEW GENES CODING NEW PROTEOLYTIC ENZYMES | 2002 |
|
RU2423525C2 |
NEW GENES ENCODING NEW PROTEOLYTIC ENZYMES | 2002 |
|
RU2296160C2 |
POLYPEPTIDES, WHICH HAVE ANTIMICROBIAL ACTION, AND POLYNUCLEOTIDES CODING THEM | 2006 |
|
RU2403260C2 |
POLYPEPTIDE WITH ANTIVIRAL, ANTIPROLIFERATIVE AND/OR IMMUNOMODULATING ACTIVITIES, SEPARATED POLYNUCLEOTIDE | 2002 |
|
RU2328528C2 |
METHOD FOR PANCREATIC CANCER DETECTION | 2012 |
|
RU2624040C2 |
POLYPEPTIDES WITH ANTIMICROBIAL ACTIVITY AND POLYNUCLEOTIDES CODING THEM | 2005 |
|
RU2393224C2 |
IMMUNITY INDUCING AGENT | 2013 |
|
RU2639518C2 |
POLYNUCLEOTIDE MODULATING CANCER CELL PROLIFERATION (VARIANTS), POLYPEPTIDE, MONOCLONAL ANTIBODY, EXPRESSION VECTOR, HOST CELL, PHARMACEUTICAL AGENT FOR TREATMENT OF PROLIFERATIVE DISEASE, PHARMACEUTICAL COMPOSITION, POLYPEPTIDE USES IN PHARMACEUTICAL AGENT PRODUCTION | 2002 |
|
RU2307666C2 |
ISOLATED NUCLEIC ACID ENCODING POLYPEPTIDE TAG 7, ISOLATED POLYPEPTIDE TAG 7, METHOD FOR INHIBITION OF TUMOR DEVELOPMENT IN MAMMALS (VARIANTS) AND METHOD FOR TREATMENT OF CANCER IN ANIMAL (VARIANTS) | 1998 |
|
RU2238976C2 |
Authors
Dates
2012-11-20—Published
2006-10-04—Filed